Mackenzie Financial
JAZZ icon

Mackenzie Financial’s Jazz Pharmaceuticals JAZZ Stock Holding History

Mackenzie Financial’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-83,456
Closed -$14.2M – 1584
2025
Q4 		$14.2M Sell
83,456
-124,210
-60% -$19M 0.02% 441
2025
Q3 		$27.4M Sell
207,666
-743
-0.4% -$89.1K 0.03% 339
2025
Q2 		$22.1M Buy
208,409
+189,412
+997% +$20.6M 0.03% 348
2025
Q1 		$2.36M Sell
18,997
-1,289
-6% -$168K ﹤0.01% 737
2024
Q4 		$2.5M Buy
20,286
+16,867
+493% +$1.99M ﹤0.01% 712
2024
Q3 		$381K Buy
3,419
+120
+4% +$13.2K ﹤0.01% 1092
2024
Q2 		$352K Sell
3,299
-29,211
-90% -$3.21M ﹤0.01% 1105
2024
Q1 		$3.91M Sell
32,510
-12,038
-27% -$1.47M 0.01% 594
2023
Q4 		$5.48M Buy
44,548
+42,675
+2,278% +$5.33M 0.01% 539
2023
Q3 		$238K Sell
1,873
-337
-15% -$44.9K ﹤0.01% 1221
2023
Q2 		$274K Buy
2,210
+145
+7% +$19.5K ﹤0.01% 1201
2023
Q1 		$302K Buy
+2,065
New +$305K ﹤0.01% 1181
2022
Q4 		– Sell
-11,498
Closed -$1.53M – 1511
2022
Q3 		$1.53M Buy
11,498
+693
+6% +$105K ﹤0.01% 751
2022
Q2 		$1.69M Buy
+10,805
New +$1.66M ﹤0.01% 755
2021
Q4 		– Sell
-12,702
Closed -$1.65M – 1468
2021
Q3 		$1.65M Sell
12,702
-1,245
-9% -$188K ﹤0.01% 789
2021
Q2 		$2.48M Sell
13,947
-2,131
-13% -$369K ﹤0.01% 684
2021
Q1 		$2.64M Sell
16,078
-21,932
-58% -$3.61M ﹤0.01% 636
2020
Q4 		$6.27M Sell
38,010
-1,428
-4% -$213K 0.01% 409
2020
Q3 		$5.62M Sell
39,438
-2,804
-7% -$348K 0.01% 387
2020
Q2 		$4.66M Buy
42,242
+23,608
+127% +$2.61M 0.01% 409
2020
Q1 		$1.86M Buy
18,634
+2,566
+16% +$332K 0.01% 516
2019
Q4 		$2.4M Buy
16,068
+2,050
+15% +$279K 0.01% 580
2019
Q3 		$1.8M Sell
14,018
-2,546
-15% -$341K ﹤0.01% 626
2019
Q2 		$2.36M Buy
16,564
+1,229
+8% +$165K 0.01% 595
2019
Q1 		$2.19M Sell
15,335
-15,240
-50% -$1.99M 0.01% 764
2018
Q4 		$3.79M Buy
30,575
+24,102
+372% +$3.58M 0.01% 573
2018
Q3 		$1.09M Buy
6,473
+112
+2% +$19.3K ﹤0.01% 743
2018
Q2 		$1.1M Buy
6,361
+219
+4% +$35.8K ﹤0.01% 674
2018
Q1 		$927K Buy
6,142
+91
+2% +$13.3K ﹤0.01% 648
2017
Q4 		$815K Buy
+6,051
New +$839K ﹤0.01% 623
2016
Q4 		– Sell
-2,228
Closed -$271K – 687
2016
Q3 		$271K Sell
2,228
-13,000
-85% -$1.75M ﹤0.01% 577
2016
Q2 		$2.15M Sell
15,228
-4,700
-24% -$693K 0.01% 423
2016
Q1 		$2.6M Buy
19,928
+3,328
+20% +$414K 0.02% 320
2015
Q4 		$2.33M Buy
16,600
+1,321
+9% +$183K 0.01% 389
2015
Q3 		$2.03M Buy
15,279
+1,300
+9% +$224K 0.01% 407
2015
Q2 		$2.46M Buy
13,979
+579
+4% +$104K 0.01% 397
2015
Q1 		$2.31M Buy
13,400
+1,800
+16% +$309K 0.01% 398
2014
Q4 		$1.9M Buy
11,600
+300
+3% +$49.8K 0.01% 429
2014
Q3 		$1.81M Buy
+11,300
New +$1.74M 0.01% 415

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Mackenzie Financial's JAZZ Position: Q1 2026 in Review

Mackenzie Financial sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2026, closing a stake of 83,456 shares — an estimated $14.2M sold.

Mackenzie Financial first reported a position in JAZZ in Q3 2014 and held it in 39 quarters. The position peaked at $27.4M in Q3 2025. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Mackenzie Financial reported no remaining Jazz Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Mackenzie Financial sold 83,456 Jazz Pharmaceuticals shares in Q1 2026, an estimated $14.2M.
  • Mackenzie Financial first reported a position in Jazz Pharmaceuticals in Q3 2014 and held it in 39 quarters.
  • Mackenzie Financial's Jazz Pharmaceuticals position peaked at $27.4M in Q3 2025.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Mackenzie Financial's 13F filing for Q1 2026, filed 13 May 2026.